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Abstract.  In cultured cells, mutants of the Adenovirus 
E/a oncoprotein which bind to a reduced set of cellu- 
lar proteins,  including pl05-Rb, p107, and p60-cyclin 
A, are transformation defective but can still interfere 
with exogenous growth inhibitory and differentiating 
signals, such as those triggered by TGF-/3. We have 
tested the ability of one such mutant,  NTdI646, to in- 
terfere with keratinocyte growth and differentiation in 
vivo, in the skin of transgenic mice. Keratinocyte- 
specific expression of the transgene was achieved by 
using a keratin 5 promoter.  Two independent lines of 
transgenic mice were obtained which expressed E/a 
specifically in their skin and exhibited an aberrant hair 
coat phenotype with striking regional variations. 
Affected hair shafts were short and crooked and hair 
follicles exhibited a dystrophic or absent inner root 
sheath.  Interfollicular epidermis was normal,  but its 
hyperplastic response to acute treatment with TPA 
(12-O-tetradecanoylphorbol-13-acetate) was signifi- 
cantly reduced. Primary keratinocytes derived from 
these animals were partially resistant to the effects of 
TPA and TGF-B.  The rate of spontaneous or chemi- 
cally induced skin tumors in the transgenic mice was 
not increased. 
Thus, expression of a transgene which interferes 
with known negative growth regulatory proteins causes 
profound disturbances of keratinocyte maturation into 
a highly organized structure such as the hair follicle 
but does not lead to increased and/or neoplastic prolif- 
eration. 
S 
ELF-renewing epithelia  are characterized by a fine bal- 
ance between growth and differentiation.  An impor- 
tant problem is how these processes are controlled. In 
the epidermis,  proliferation  is normally confined to keratino- 
cytes of the basal layer while cells of the upper layers termi- 
nally differentiate  (Fuchs,  1990). A more complex program 
of keratinocyte growth and differentiation  is involved in for- 
marion of skin appendages such as hair follicles (Sterm et al., 
1991). The mature hair follicle consists of several concentric 
epithelial  layers, of which the innermost ones make up the 
hair shaft. Each follicle undergoes repeated cycles of growth 
(anagen), regression (catagen),  and quiescence (telogen). In 
the growth phase, the relatively undifferentiated  and actively 
dividing cells of the lower portion, or "bulb; move upwards 
and differentiate into the several concentric epithelial  layers 
of the upper region. In turn, the proliferating  bulbar cells ap- 
pear to arise from stem cells situated  in the "bulge; in the 
upper region of the hair follicle (Cotsarelis et al., 1990). The 
importance of this region for keratinocyte self-renewal is in- 
dicated by both hair follicle (Oliver, 1966; Inaba et al., 1979) 
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and epidermal (Lenoir et al.,  1988; Limat et al.,  1991) re- 
generation  experiments.  This upper portion of the follicle, 
rather than the epidermis, is also thought  to contain target 
cells for cutaneous carcinogenesis  (Berenblum et al., 1959; 
Argyris, 1980. Keratinocytes in both epidermis and hair fol- 
licles are dependent on intimate interactions  with the under- 
lying mesenchymal tissues (for example, see Billingham and 
Silvers,  1967; Salag et al.,  1985; Oliver and Jahoda, 1988; 
Coulomb et al.,  1989; Hirai et al.,  1992). 
Previous studies have shown that the Adenovirus  E/a on- 
cogene can be used to probe into complex regulatory func- 
tions,  involved  in  keratinocyte growth and  differentiation 
(Barrandon  et al.,  1989; Pietenpol et al.,  1990; Missero et 
al.,  1991a,b).  The immortalizing  and transforming  activity 
of this oncogene depends on its binding  to a specific set of 
cellular proteins,  including pl05-Rb, p107, and p60-cyclin A 
(for review see Nevins, 1992). It has been shown that E/a can 
interfere with the function of these latter proteins by causing 
their  dissociation  from  specific  transcriptional  complexes 
(Bagchi et al., 1990; Chellapan  et al.,  1991; Mudryj et al., 
1991; Cao et al., 1992; Ewen et al., 1992). Besides transfor- 
marion, binding of  E/a to these proteins interferes with trans- 
mission of exogenous growth inhibitory and differentiating 
signals  of the kind triggered  by TGF-B (Pietenpol  et al., 
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mutants which bind to p105, p107, and p60-cyclin A can still 
interfere with the normal TGF-B response, even if to a lesser 
extent than wild-type E/a. Like with TGF-B, the sensitivity 
of keratinocytes to phorbol esters (12-O-tetradecanoylphor- 
bol  13-acetate[TPA]),  elevated cAMP levels  or corticoste- 
roids can be at least partially suppressed by these E/a mu- 
tants (Missero et al., 1991a; Florin-Christensen et al., 1992, 
1993) 
In parallel with these activities, E/a can block growth- 
inhibitory and differentiating signals involved in control of 
skin tumor development (Missero et al., 1991b). Tumorige- 
nicity of keratinocytes transformed by a single ms oncogene 
can be suppressed by dermal fibroblasts, through the produc- 
tion  of a  diffusible TGF-fl  factor.  Resistance  to  dermal 
fibroblast-tumor inhibition was  observed  in  keratinocytes 
concomitantly transformed by ms and E/a or a truncated E/a 
mutant which binds to p105, p107, and p60. 
Complex growth inhibitory and/or differentiating signals 
may be operative in the intact skin, which cannot be taken 
into account in culture and/or in simple tumorigenicity as- 
says. Our previous studies suggest that heterotypic cell-cell 
interactions, such as those mediated by TGF-B production, 
can play an important role in skin tumor control and, more 
generally,  in  normal  skin  homeostasis  (Missero  et  al., 
1991b). To further test this model, we have generated trans- 
genic mice which specifically express in their epidermis a 
transformation defective E/a mutant (NTdl646)  which retain 
the ability to bind to the pi05, p107, and p60 proteins (Whyte 
et al., 1989). Transgenic mice expressing the entire Adeno- 
virus E/region from the MMTV promoter have been previ- 
ously described (Koike et al.,  1989).  The complex pheno- 
type that was found in that case, multifocal minors at the 
squamocolumnar junction of the stomach, is likely to be a 
result of the cooperative activity of the E/a and E/b onco- 
genes. For our studies, the E/a NTdl646 mutant was chosen 
to disrupt negative regulatory loops involved in maintenance 
of a normal epidermal tissue without eliciting direct growth 
stimulatory and/or transforming effects.  Transgenic  mice 
with skin-targeted expression of positive growth-regulatory 
molecules such as activated ms (Bailleul et al.,  1990)  and 
BNLF-1 (Wilson et al., 1990) oncogenes, and TGF-B (Vassar 
and Fuchs, 1991) have been previously reported. In the latter 
two cases,  an hyperplastic epidermis was observed.  With 
ras, an hyperkeratotic epidermis  was  formed which pro- 
ceeded to yield benign papillomas. In contrast, the epider- 
mis of transgenics carrying the truncated E/a oncogene was 
normal and its rate of tumor conversion was not increased. 
Rather than in the epidermis, there were widespread abnor- 
malities in the hair follicles, with aberrant hair shafts and ab- 
sent or markedly dystrophic inner root sheaths. 
Materials and Methods 
Plasmid Construction and Characterization 
A 900-bp portion of the keratin 5 promoter was obtained from a mouse 
genomic DNA library by PCR amplification,  from position -807 to posi- 
tion +90 of the published sequence (Lersch et ai.,  1989) and cloned into 
1. Abbreviations used in this paper: DMBA,  7,12-dimethylbenz[A]anthra- 
cene; IRS,  inner root sheath; ORS, outer root sheath; TPA,  12-O-tetra- 
decanoylphorbol  13-acetate. 
the ClaI site of Bluescript KS  + (Stratagene,  La Jolla, CA).  The SV-40 
pelyadenylation  site (from position  +2560 to  +3007 of the SV-40 se- 
quence) was inserted behind the K5 promoter at the PstI-BamHI sites. Fi- 
nally, a G418-resistance  gene driven from the SV-40 early promoter (from 
nucleotide  +3393 to +5734 of pSV2-neo) (Southern and Berg,  1982) was 
inserted at the Notl site. 
The coding region of the E/a NTdI646 gene was excised from the plasmid 
vector (Whyte et al.,  1989) by digestion with NcoI (which cuts just up- 
stream of the E/a initiation codon) and PstI (at the 3' end of the gene) and 
inserted at the unique EcoRV site of the plasmid vector (K5T),  behind the 
K5 promoter and in front of the SV-40 polyA site. 
Transgenic Mice Generation 
A 2.6-kb DNA fragment containing the K5 promoter, the E/a NTdI646 gene 
and the SV-40 polyadenylation signal (BamHI cassette) was purified and in- 
jected into the male pronucleus of fertilized eggs from (C57BL/6 ×  SJL) 
F1 mice as described (Hogan  et ai.,  1985).  18 offsprings  were obtained 
which were screened for foreign DNA after reaching 3 wk of age. Dot blot 
analysis was performed with 10/~g of purified genomic DNA using an E/a- 
specific probe (nucleotides  +646 to  +1007 of the E/a sequence). DNA 
from the E/a-positive mice was cleaved with EcoRI and BgllI and analyzed 
by 1% agarose gel electrophoresis and Southern blotting with the E/a probe 
to test whether the integrated DNA was intact. 
For subsequent analysis of newborn litters,  tail DNA was subjected to 
PCR analysis with E/a-specific primers corresponding to nucleotides +877 
to +897 and +1073 to +1093 of the E/a gene, followed by agarose gel elec- 
trophoresis.  PCR reactions with primers for the endogenous mouse aetin 
gene were run as controls. 
Histology and Immunohistochemistry 
Formalin-fixed tissues were sectioned  and stained with haematoxylin and 
eosin. For EM, specimens were fixed in glutaraldehyde  as previously de- 
scribed (Filvaroff et al.,  1990).  For immunohistochemistry, tissues were 
fixed in 3% paraformaidehyde  for 1 h at 4°C. Paraffin sections were subse- 
quently incubated with anti-E/a M73 mAbs 0:10 dil., Oncogene Science, 
Inc., Manhasset, NY) overnight at 4°C, with biotinylated goat anti-mouse 
antibodies for 1 h at room temperature, and with Streptavidin peroxidase 
(1:20 dilution; Zymed Labs, Inc., San Francisco,  CA) for 30. Slides were 
reacted  with 0.1% (wt/vol)  3-Ydiaminobenzidine  (Sigma  lmmunochemi- 
cais,  St. Louis,  MO). Sections  were counterstained with 5% Light Green 
SF Yellowish (Fisher Scientific,  Pittsburgh, PA). 
Ribonuclease Protection Assays 
Tissues were pulverized after quick freezing in liquid nitrogen.  Total RNA 
was  extracted  by  the  method  of  Chomszynsky  and  Sacchi  (1987). 
Ribonuclease protection assays  were performed as previously described 
(Missero et ai., 1991b) using 50/~g of tissue RNA and an RNA probe corre- 
sponding to nucleotides  +646 to +1007 of the E/a gene. An RNA probe 
for rat glyceraldebyde-3-phosphate  dehydrogenase  (GAPDH) (Tso et ai., 
1985) was also used to control for mRNA levels in the various samples. 
Probes were prepared after plasmid linearization, by in vitro transcription 
with T7 polymerase (Stratagene)  in the presence of c~32P-UTP (10 mCi/ml, 
400 Ci/mmol, Amersham Corp., Arlington Heights,  IL). 
Immunoblotting 
Cells or pulverized tissues were dissolved  in sample buffer (Laemmli, 
1970), boiled for 5' and analyzed by SDS-PAGE and immunoblotting with 
anti-E/a M73 mAbs (1:20 dilution; Oncogene Science,  Inc.).  Antibody 
binding was detected by incubation with 12sI-protein A (100/~Ci/ml; ICN 
Biochemicais,  Irvine, CA). The various samples were normalized for pro- 
tein content by gel electrophoresis and staining with Coomassie blue. 
Cell Culture and Assays 
Parn212  cells (Yuspa et al.,  1980)  were  transfected with the K5T and 
K5T/E/a646 plasmids,  as previously described (Missero et al.,  1991a). 
G418-resistant colonies were pooled and amplified before testing.  Primary 
keratinocytes from newborn mice were prepared and cultured as previously 
described (Hennings et ai.,  1980;  Dotto et ai.,  1988). 
Mitogenicity assays were performed as previously described (Missero ct 
al.,  1991a).  TPA  was  purchased  from  Chemsyn  Science  Laboratories 
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were labeled by a 1-h pulse with [Methyl-3H]thymidine (3.3 ttCi/ml; 40-60 
Ci/mmol; ICN Biomedicals, Costa Mesa, CA). Epidermal transglutamin- 
ase activity was measured by [3H]putrescine incorporation as previously 
described (Filvaroff et al.,  1990). 
Tumor Induction Experiments 
E/a-positive and -negative mice in the resting phase of the hair cycle (6-7 
wk old) were shaved and treated with DMBA (20 ttg in 200 #1 acetone) 48 h 
after shaving.  Mice were subsequently treated twice a  week with TPA 
(10  --4 M  in acetone) for 7  mo.  These experiments were performed with 
transgenics in a Sencar background (F4 and F5 generations)  and the Ela- 
negative mice used as controls were derived from the same litters as the 
transgenics. DMBA was dissolved in acetone just before use. TPA solution 
was stored at -70"C. Papillomas were excised for histological examination 
at different stages of their growth. 
For experiments involving DMBA, Ela-positive and -negative mice from 
the same litters were exposed to a single dose of this agent 1-3 d after birth 
via intraperitoneal injection. Relative to topical treatment ofedult mice, this 
way of administration is equally effective for skin tumor induction (Hen- 
nings et al., 1981) and has the potential advantage of hitting target keratino- 
cyte populations in mice of younger age, at a time when the effects of E/a 
expression appear to be more evident. For these experiments DMBA was 
first dissolved in DMSO, diluted in SSV buffer (Hennings et al., 1981) and 
injected at 20 tzg per mouse in a 25/~1 volume. Mice were kept for examina- 
tion until 8 mo of age. 
Results 
Construction of  a Keratinocyte-specific  Ela Expression 
Vector and Generation of Transgenic Mice 
A previous study has indicated that the first 900 nucleotides 
in front of the human keratin 5 gene are sufficient to drive 
specific expression of this  gene in  cultured keratinocytes 
(Lersch et al., 1989). For the present work, this 900-bp pro- 
moter sequence was used to drive specific expression of the 
E/a NTdI646 gene in keratinocytes of transgenic mice. This 
gene lacks the sequence for the first 29 amino acids of E/a. 
This deletion prevents binding of E/a to a p300 cellular pro- 
tein without affecting association with p105, plffT, and pt0. 
The NTd1646 gene lacks the immortalizing and transforming 
activity of the full E/a gene (Whyte et al., 1989), but retains 
the  ability  to  interfere  with  the  growth  inhibitory  and 
differentiating  effects  of  TGF-/~, TPA,  cAMP,  and  cor- 
ticosteroids (Missero  et al.,  1991a;  Florin-Christensen et 
al.,  1992; our own unpublished observations). 
A construct carrying the E/a NTd1646 gene behind the K5 
promoter (K5T/E/a646; Fig. 1 A) was transfected into estab- 
lished Pam212 keratinocytes (Yuspa et al.,  1980). As previ- 
ously described for the E/a NTdI646 gene driven by its own 
adenoviral promoter (Missero et al.,  1991a),  K5T/E/a646 
induced '~40 % resistance to TGF-/~ growth inhibition (data 
not shown). 
K5T/E/a646 was used to generate transgenic mice, by in- 
jection of purified insert DNA (BamHI cassette, Fig.  1 A) 
into fertilized eggs from (C57BL/6  x  SJL) F~ mice. 5 out 
of 18 newborn mice were found to be positive for the trans- 
gene, and each carried '~4 copies of unrearranged DNA, as 
judged by Southern blotting and dot blotting of  chromosomal 
DNA alongside serial dilutions of vector DNA  standards. 
Transgenic  lines  for  further  analysis  were  generated  by 
breeding all positive founders with Sencar mice. This strain 
of mice was chosen because of its intrinsic sensitivity to skin 
carcinogenesis  (Hennings  et al.,  1981),  which  might  en- 
hance whatever growth-related effect  the truncated E/a trans- 
l~gure 1. Map of the K5T/Ela646 construct and expression of the 
E/a transgene. (,4) The BamHI cassette used for transgenic mice 
construction, containing the K5 promoter, the E/a NTdI646 gene 
and the SV-40  polyadenylation site. (B) Ribonuclease protection as- 
say with an E/a-specific probe to determine tissue specificity of ex- 
pression  in an F2 906T  mouse.  Ribonuclease protection with a 
GAPDH  RNA  probe was  used  as  an  independent  measure  of 
mRNA amounts present in the individual tissue preparations. A 
weak positive signal, detectable in the stomach and intestine sam- 
pies, was lost after photographic reproduction. A similar pattern 
of E/a expression was observed in two other 906T and one 901T 
mice. (C) Immunoblotting with anti-E/a mAbs to determine ex- 
pression of  the E/a NTdI646 protein in Pam212 keratinoeytes trans- 
fected with the KSTIE/a646 construct (+) or the K5T vector alone 
(-), primary keratinoeytes derived from E/a-positive mice (+) and 
E/a-negative littermates (-), and whole skin of  a 906T E/a-positive 
mouse (+) and an E/a-negative littermate (-). Molecular weight 
markers are indicated in kD. 
gene might have. One of the E/a-positive founders failed to 
transmit the gene to the progeny. Of the other four, two, 901T 
and 906T, showed similar hair coat abnormalities (see be- 
low),  which  were transmitted  to  the offspring.  The 901T 
founder was albino and gave rise only to albino mice. 906T 
was agouti and, when crossed with the Sencar albinos, gave 
rise to E/a-positive offsprings with all possible coat color 
combinations, indicating that the inserted transgene was un- 
linked to either the agouti or albino loci. 
Macroscopic Abnormalities in the Ela 
NTdl646 Transgenics 
Positive mice were clearly distinguishable a few days after 
birth because of a striped hair coat, resulting from areas of 
shorter and wrinkled hair shafts alternating with bands of 
Missero et al. Skin-specific Expression of Ela in Transgenic Mice  1111 Figure 2. Aberrant hair coat phenotype in the E/a NTdI646 trans- 
genies. (a) An E/a-positive 901T mouse at 7 d of age along with 
an E/a-negative littermate; (b) two E/a-positive 906T mice along 
with an E/a-negative sibling at 10 d of age; and (c) an E/a-positive 
906T mouse with particularly strong phenotype at 1 mo of age. The 
well demarcated bald area occurred spontaneously. 
normal looking hair (Fig. 2, a and b). The stripes of affected 
hair rarely crossed the midline and their location remained 
constant throughout the lifetime of the animal. 
This striped pattern occurred independently of hair color, 
sex, and sex of affected parent. Some 906T mice, especially 
in the F2 and F3 generations, exhibited a  stronger pheno- 
type, which included larger and irregular areas of very poor 
hair growth and/or baldness (Fig. 2 c). As with the stripes, 
these areas of baldness did not cross the midline but could 
sharply terminate there (Fig. 2 c). In these same areas, thin 
pigmented lines could be detected. With time (as early as 
3--4 wk of age) some of the bald areas evolved into ulcers 
(data not shown).  Since such destructive lesions could be 
found at the base of the neck, and in mice that were caged 
individually, it is unlikely that they were the result of trauma, 
such as biting or scratching. In the most severely affected 
animals, the hair abnormality was present universally on all 
skin surfaces with some hair gradually growing later in life. 
The weak and strong phenotypes were equally observed in 
inbred litters of E/a-positive transgenics and outbred litters 
of E/a-positive males with normal Sencar females. 
Besides hair coat abnormalities, the only other macro- 
scopical  phenotypic  alteration  present  in  some  newborn 
animals was a persistent crust in the eye, without effects on 
the opening of the lid. The crust was eventually eliminated 
by 2-3 wk of age. E/a-positive mice were often smaller than 
their E/a-negative littermates at birth,  but this difference 
tended to disappear by 3-4 wk of age. Autopsy revealed no 
macroscopic or histologic abnormalities of the various inter- 
nal organs. 
Histological Abnormalities 
Use  of a  dissecting microscope revealed that,  relative to 
neighboring regions, hair shafts in the affected stripes were 
shorter and crooked (Fig. 3, a-c). These hair abnormalities 
were particularly evident in agouti mice, where the alternat- 
ing transversal bands of yellow and black pigment  -  intrinsic 
to the agouti phenotype-produced an impression of abnor- 
mal pigmentation. Very short and irregular shafts were pres- 
ent also in the bald areas. Overhairs-including vibrissae- 
and underhairs were similarly affected. The shafts appeared 
thinner and wavy but the tips were tapered as in normal hairs 
and fractured forms were not seen (Fig. 3, c-e). Hair shafts 
from individual mice collected and analysed for amino acid 
content. Variations in individual aminoacid were <1% except 
for citruUine and ornithine-an enzymatic conversion prod- 
uct of trichohyalin (Rogers etal., 1991): a 30% decrease of 
these particular  aminoacids was consistently observed  in 
each of five E/a-positive mice versus five E/a-negative sib- 
lings. 
Hair follicles were directly visualized after removal of  der- 
mal  collagen by  acid  extraction  (Schweizer  and  Marks, 
1977).  This technique revealed that hair follicle density was 
only slightly reduced in the E/a-positive mice, even in their 
striped and bald areas, but follicles were generally smaller 
and erratic in shape compared with the controls. 
Severely affected follicles were often located next to rela- 
tively normal ones. By high power light microscopy, no ab- 
normalities were notable in the dermal papilla, or the lower 
bulb.  Cells in the upper area of the bulb were slightly re- 
duced in number and size and had an abnormal shape and 
organization. The most obvious changes were apparent in the 
inner root sheath (IRS) with disruption of the Huxley's and 
Henle's layers and dilated cells with a  reduced content of 
trichohyalin granules (Fig. 4, c and d). The hair shaft was 
often prematurely separated from the IRS and showed sub- 
stantial irregularities in width and a reduction of trichohyalin 
granules in the medulla. In contrast to IRS and hair shaft, 
the outer root sheath was usually normal. Focal disruption 
of the outer root sheath (ORS)  could however be found at 
sites of ulceration (see below).  These findings were con- 
firmed by EM,  with cells of the IRS lacking the typical 
differentiation features of both Huxley's and Henle's layers 
(Fig. 5). 
The Journal  of Cell Biology,  Volume 121, 1993  1112 Figure 3. Hair coat abnormalities as observed microscopically. (a-c) striped hair coat of a 906T mouse as seen under a dissecting micro- 
scope at increasing magnification. (d and e) Hair shafts from an Ha-negative and -positive littermate, respectively, as seen by light micros- 
copy. Bars: (a) 300 #In; (b) 150 #in;  (c) 60 #m; and (d and e) 75 #m. 
The epidermis of the E/a-positive mice was normal (Fig. 
4, a  and b), except for mild thickness and scaling in some 
markedly affected newborns. The healing process after full 
thickness wounding was normal. Areas of spontaneous ul- 
ceration were characterized by a marked epidermal hyper- 
plasia  surrounding  the  ulcer  and  an  inflammatory  and 
reparative response of the dermis which contained very few 
residual hair follicles. No signs of  infections were detectable 
at these locations. To determine the histogenesis of these le- 
sions, we examined a set of eight mice at a rather young age 
(3 wk), with a very strong phenotype and with already small 
ulcers. Limited foci of epidermal hyperplasia were found in 
the bald but intact areas. Much more pronounced hyperpla- 
sia was found along the margin of the small ulcers. The wall 
of the hair follicles in these areas was irregularly thinned and 
showed focal infiltration of  acute inflammatory cells. At least 
in some cases, it was possible to demonstrate that the ORS 
was focally disrupted. This histological picture is similar to 
human perforating folliculitis and is consistent with a deep 
folliculitis being responsible for the observed ulceration and 
scarring. 
No signs of spontaneous tumorigenic conversion was ever 
detected over a period of 12 mo either at these locations or 
anywhere else in the skin of the affected animals. 
Correlation of Phenotype with Preferential 
K3T/E1a646 Expression in the Skin 
Total RNA  was  prepared from the  skins  of F~  mice and 
analyzed by  ribonuclease  protection assays  with  an  E/a- 
specific probe. E/a expression was found in the two families 
with positive phenotype, 901T and 906% while the other two 
families showed no detectable expression (data not shown). 
E/a expression in 901T mice was found to be consistently 
lower (two- to-threefold in three independent measurements) 
than in the 906T. For most of the biochemical and functional 
assays reported hereafter we have focused on the 906T mice. 
Tissue specific expression of  the transgene was assessed by 
ribonuclease protection assays with total RNA derived from 
various tissues. As shown in Fig. 1 B, E/a was preferentially 
expressed in the skin, with much weaker levels of expression 
detectable in the stomach and intestine. In all other organs 
Missero et al. Skin-specific Expression of Ela in Transgenic  Mice  1113 Figure 4.  Histology of the skin of E/a NTd1646 transgenics.  (A and B) Low power magnification  of the skin from an E/a-negative (.4) 
and E/a-positive (B) littermates.  Note the abnormal and crooked hair follicles  with a normal, nonhyperplastic epidermis in the affected 
animal.  Early and irregular separation  of the hair shaft from the sheath could b¢ typically observed. (C and D ) High power magnification 
of  a hair follicle from the E/a-negative and E/a-positive mice. Note the normal layering of  the control follicle (C) with clearly distinguishable 
ORS,  Henle's  and Huxley's layers,  cuticle,  cortex, and medulla.  Notice that the medulla has a regular width and the medullary spaces 
are filled with melanin and trichohyalin granules.  The affected follicle (D) contains an irregularly shaped shaft with open medullary spaces, 
with normal melanin but substantially  reduced trichohyalin granules.  The wall lacks the typical layering of  the normal follicle. In particular, 
the region corresponding to the putative IRS shows a markedly dystrophic structure and lacks the typical features  of both Huxley's and 
Henle's  layers.  Haematoxylin and eosin. Bars: (A and B) 200 ~m; (C and D)  15 ~m. 
The Journal of Cell Biology,  Volume 121, 1993  1114 Figure 5. EM of hair follicles from control (,4) and transgenic (B) littermates. Note the normal structure of the control follicle with the 
ORS, Henle's (Hen), and Huxley's  layers (Hux), cuticle (cut), cortex (cor), and medull  a (reed). The wall of the affected  follicle is distinctly 
disorganized with swollen cells without trichohyalin granules in the area of the Huxley's layer (Hux) and an irregular to absent Henle's 
layer (Hen). The layering of the shaft is relatively normal, but the medullary spaces are wider and have a reduced number of granules. 
The differences  in thickness of  the cortex and keratinization  levels between  A and B are not significant  as they are due to the slightly different 
level of the follicle from which these two sections were taken. Bar, 5 #m. 
E/a expression remained undetectable, including the esopha- 
gus. This organ contains a stratified epithelium where the K5 
keratin is usually expressed (Fuchs and Green, 1980;  Moll 
et al., 1982).  The lack of expression of the E/a transgene in 
this location may be due to the relatively small K5 promoter 
region used for these studies. 
The E/a gene products migrate as a set of bands as a result 
of differential splicing and phosphorylation (Boulanger and 
Blair,  1991). Expression  of  E/a  NTdI646  proteins  was 
verified by immunoblot analysis of whole skin extracts of the 
transgenic mice with anti-E/a M73 mAbs (Fig.  1 C). Pri- 
mary keratinocytes derived from the E/a transgenics were 
also found to express these proteins (Fig. 1 C), while dermal 
fibroblasts did not (data not shown). This analysis was com- 
plemented by an immunohistochemical study with the same 
antibodies to determine expression of the E/a protein in the 
skin in situ. Specific nuclear labeling was found in keratino- 
cytes of both hair follicles (primarily in the ORS) and, to a 
lesser extent, epidermis (Fig. 6). Interestingly, staining was 
not homogeneous, but in patches, suggesting local variations 
in levels of  E/a expression between neighboring hair follicles 
and epidermal keratinocytes. 
Response of Transgenic Keratinocytes  to TGF-B 
Growth Inhibition 
Primary keratinocytes derived from the E/a transgenics were 
tested for TGF-B sensitivity. Newborn litters obtained from 
crosses of Fz 906T males with Sencar females were sepa- 
rated into Ha-positive and -negative groups by PCR analysis 
of tail DNA. Primary keratinocytes were prepared from the 
two groups of  mice and E/a expression was confirmed by im- 
munoblotting with E/a-specific antibodies (Fig. 1 C). Mito- 
genie response of  these cells was determined after 20 h incu- 
bation with TGF-B at various concentrations (Fig. 7 A). In 
five independent experiments,  DNA synthesis of the E/a- 
positive cells was found to be consistently less inhibited than 
that of their E/a-negative counterparts. However, this differ- 
ence was never greater than 20%  and was not observed at 
high TGF-fl concentrations (>1  ng/ml). 
Thus, expression of a truncated E/a NTd1646 gene in the 
transgenlc keratinocytes interferes only partially with TGF-# 
growth inhibition. 
Resistance of Transgenic Keratinocytes  to TPA Effects 
both In Vitro and In Vivo 
Phorbol esters such as TPA (12-O-tetradecanoylphorbol-13- 
acetate) act as potent modulators of keratinocyte growth and 
differentiation, under both in vitro and in vivo conditions 
(Steinert and Yuspa,  1978;  Balmain,  1978;  Bhisey et al., 
1982; Yuspa et al., 1982; Reiners and Slaga, 1983). Mitoge- 
nicity assays similar to the ones described above were used 
as a first test of the sensitivity of E/a-positive and -negative 
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genic  mice as determined  by immunohistoehemistry.  (A and B) 
Epidermis from a 906T E/a-positive mouse (2 wk old) staitied with 
anti-E/a mAbs (A) or nonimmune antibodies (B); (C and D) a hair 
follicle of the same mouse stained with anti-E/a mAbs (C) or non- 
immune antibodies (D). White arrows point to the specific nuclear 
labeling with the anti-E/a mAbs. Note inA the heterogeneity of  E/a 
staining between adjacent epidermal keratinocytes. Bar, 90 t,m. 
primary keratinocytes  to  the  growth  inhibitory  effects of 
TPA.  DNA synthesis of E/a-positive cells was found to be 
inhibited by this agent but to a significantly lesser extent than 
that of their negative counterparts, and this difference was 
maintained even at high TPA concentrations (Fig. 7 B). In 
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Figure  Z In  vitro  response of  transgenic  primary keratinocytes  to 
TGF-/~ and  TPA. Primary keratinocytes  derived from 906T E/a- 
positive mice (m) and E/a-negative littermates  (ta) were tested for 
their sensitivity to growth inhibition by TGF-/~  and TPA (A and B, 
respectively)  and  epidermal  transglutaminase  induction  by TPA 
(C). Cells were tested  in  triplicate wells and standard deviation was 
as  indicated.  Cells  were incubated  with  fresh  medium plus/minus 
TGF-~ I  or  TPA for  20  h. DNA  synthesis  was measured by a l-h 
pulse  with  [Methyl-3H]thymidinc and  expressed  as  percentage  val- 
ues relative  to untreated controls.  Epidermal transglutaminase 
activity  was measured by [3H]-putrescine  incorporation  and ex- 
pressed as fold  induction  of  treated  versus  untreated  controls. 
enzymatic marker of keratinocyte differentiation,  was in- 
duced by TPA to substantially lower levels of E/a-positive 
keratinocytes than in the negative controls (Fig.  7  C). 
To test whether there was a decreased responsiveness to 
TPA in vivo, groups of E/a-positive and -negative mice were 
treated with this agent or acetone and sacrificed 72 h  later 
(Fig. 8). Serial sections of the skin of each of these animals 
revealed a strong and homogeneous hyperplastic response in 
the E/a-negative mice (Fig. 8 C). In contrast, the epidermis 
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transgenic mice to acute TPA 
treatment. A group of six E/a- 
negative and six E/a-positive 
littermates  (1  mo  old)  were 
shaved and  24  h  later topi- 
caUy treated with TPA (5  x 
10  -5 M, 400 ~1, in acetone) 
and sacrificed 3 d later. Shown 
is a representative picture of 
the  skin  of an  E/a-positive 
mouse treated with acetone (A) 
or TPA (B) or of an E/a-nega- 
tive sibling treated with TPA 
(C). Bar, 152 ~m. 
of the  E/a-positive animals  showed  only regions  of mild 
hyperplasia, which alternated with others where the hyper- 
plastic response was totally absent (Fig.  8 B). 
Thus  the E/a-expression keratinocytes are  substantially 
less responsive to the biological effects of TPA under both 
in vitro and in vivo conditions. 
Tumor Induction in Ela-positive and-negative Mice 
Spontaneous skin tumor development has not been detected 
so far in our E/a transgenics (at 15 mo from the beginning 
of  the  experiments).  Similarly,  initiation  of  mice  with 
DMBA  (7,12-Dimethylbenz[a]anthracene)  without  subse- 
quent tumor promotion elicited no skin tumor development 
in either E/a-positive or -negative mice (Table I). 
A  complete  initiation-promotion protocol  with  DMBA 
and TPA resulted in efficient papilloma formation in both 
positive  and  negative  mice  (Table  I).  There  were  no 
significant differences between the two groups in either time 
of appearance, size, and rate of tumor growth. The numbers 
of papilloma-bearing animals and of papillomas per mouse 
were somewhat lower with the E/a-positive mice than with 
the negative controls. The histological characteristics of the 
papillomas obtained in the two cases were very similar (data 
not shown). Only one carcinoma developed so far from one 
E/a-negative mouse (at 7 mo from the beginning of the ex- 
periment). We conclude from these studies that expression 
of the truncated E/a NTd1646 gene is unlikely to favor ker- 
atinocyte tumor development (at least as tested in the Sencar 
genetic background),  nor does it influence its histological 
type. 
Table L  Chemically Induced Tumors in Ela-positive and 
El  a-negative Mice 
DMBA*  DMBA  +  TPA* 
Mice with  Mice with  Papillomas 
tumors  papillomas  per mouse 
Ela-positive  0/15  28/38  {33/37]  5.6  [9. 7] 
Ela-negative  0/12  13/13  {13/13]  10.8  {16.1] 
* Mice were exposed to a single dose of DMBA either  1-3 d after birth via in- 
traperitoneal injection (20 tag/injection, as described in Materials and Methods) 
or at 7 wk of age by topical application (4 t~g/200 tal acetone). Duration of the 
experimenti  9 too. 
* Mice were exposed to a single dose of DMBA (4 tag/200 tal acetone) at 7 wk 
of age  followed by biwceidy treatments with TPA  (10  --4 M, 200 td,  in ace- 
tone).  Values are given after 2 and 4 (brackets) mo. Tumor size varied sig- 
nificantly between and within individual animals, with no consistent differences 
observed  between the Ela-positive and -negative groups. 
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An increasing number of negative growth regulatory genes 
are being identified which are deleted and/or functionally 
suppressed in tumor cells (Stanbridge,  1990).  The specific 
consequences  of  loss  of  these  genes  for  normal  tissue 
homeostasis and neoplastic development are currently being 
investigated (Donehower et al., 1992; Lee et al., 1992; Jacks 
et al., 1992).  We have attempted to address this question in 
mouse skin, by using a transformation-deficient E/a mutant 
(NTdI646)  which interferes with a specific set of cell nega- 
tive regulatory proteins of which pl05-Rb, p107, and p60- 
cyclin  A  are  probably  the  best  characterized  ones  (as 
reviewed by Boulanger and Blair,  1991). 
Expression of the E/a NTd1646 transgene did not lead to 
detectable alterations of the epidermis while hair follicles 
were substantially abnormal. The main defect appeared to 
be an absent or markedly dystrophic IRS, with an impaired 
function as a guide and mold for the nascent hair shaft. A 
fine balance must exist between growth of keratinocytes in 
the bulbar part of the hair follicle and their differentiation 
and organization into the upper structure. In vivo [3H]thy- 
midine  incorporation  experiments  with  E/a-positive  and 
-negative siblings, revealed no differences in the number of 
dividing cells below the Auber's line of the bulb and along 
the base of the ORS (data not shown). Given this similar 
growth kinetic, the significantly shorter hair shafts found in 
the E/a-positive mice are probably due to a shorter hair cy- 
cle, with follicle cells entering catagen sooner than in the 
controls. 
Maturation ofbulbar cells into Huxley's and Henle's layers 
of the IRS was particularly affected. Immunohistochemical 
data indicated that expression of the E/a transgene, similar 
to that reported for keratin 5 (Heid et al., 1988), was limited 
mostly to the bulb and the ORS, while it was rarely found 
in the IRS (and never in the hair shaft). It has been previously 
proposed that IRS development depends on interacting ORS 
signals (Stralle, 1962),  which could be transmitted through 
processes (Flugelzellen) connecting cells of  the ORS to those 
of Henle's and Huxley's layers (Clemmensen et al.,  1991). 
Thus, expression of the E/a transgene, besides having a di- 
rect effect on bulbar cells maturation, may also alter the abil- 
ity of ORS cells to support IRS formation and function. 
Within the same mouse, hair follicle abnormalities showed 
a very interesting pattern of spatial localization with horizon- 
tal  stripes  and more  extensive areas  of baldness  sharply 
limited by the midline. Transgenic mice with a striped hair 
coat phenotype have been previously described, with aber- 
rant keratin expression causing breaking of the hair shaft and 
cyclic hair loss (Powell and Rogers, 1990).  The discrete lo- 
calization of hair follicle abnormalities found in our mice 
was independent of the hair cycle and constant over time. 
This pattern could be explained by parallel spatial variations 
in E/a expression within the skin. This situation would be 
reminiscent of a recently described strain of transgenic mice 
characterized by different expression levels of the transgene 
in clones of genetically identical melanocytes (phenoclones) 
(Mintz and Brad, 1991). Similarly, our immunohistochemi- 
cal data indicate that levels of E/a expression are not homo- 
geneous, but differ between neighboring hair follicles and 
groups of keratinocytes in the epidermis. However,  direct 
measurements of E/a RNA expression in transgenics with a 
strong phenotype failed to reveal any significant differences 
between well defined areas of "baldness" and neighboring, 
less affected regions (data not shown). Thus, besides varia- 
tions in E/a expression, the discrete hair follicle abnormali- 
ties observed in our transgenics may be due to different E/a 
effects,  depending on the lower or higher concentrations 
of some  as  yet undefined determinant(s)  of hair  follicle 
function. 
Very  little is known about the molecular signals which 
control hair follicle formation. A possible role for TGF-/~ 
factors  has  been  suggested  by  immunohistochemical 
methods which have revealed high concentrations of these 
molecules  in  developing  hair  follicles  and  surrounding 
mesenchyme (Heine et al., 1987; Pelton et al., 1991). Trans- 
genic primary keratinocytes expressing the E/a  NTd1646 
gene showed only a partial reduction in TGF-/3 sensitivity, 
as measured by in vitro growth inhibition assays.  However, 
E/a NTd1646 may interfere significantly with other aspects 
of TGF-~ action, especially in a complex in vivo situation 
such as that of the hair follicle. Furthermore, stronger inter- 
ference with TGF-~ signaling could occur in vivo due to the 
higher expression of  the E/a NTdI646 gene in the intact skin. 
Besides TGF-/~, hair follicle function may be under the con- 
trol of other diffusible messengers such as cAMP, retinoids 
and corticosteroids. Expression of the E/a NTdI646 gene in 
established Pare212 keratinocytes can interfere with these 
agents (Florin-Christensen et al., 1992; unpublished obser- 
vations) and it may have similar effects in keratinocytes of the 
skin. 
In contrast to the substantial alterations found in hair folli- 
cles, very little changes were observed in growth/differentia- 
tion of interfollicular epidermal cells under basal conditions. 
However, their hyperplastic response to acute TPA treatment 
was significantly reduced, with spatial variations that are 
reminiscent of those of hair follicle abnormalities. The in 
vivo findings were corroborated by in vitro studies. Primary 
keratinocytes derived from the E/a transgenics responded 
normally to the growth/differentiating effects of increased 
extracellular calcium (data not shown).  In contrast, their 
sensitivity to the effects of TPA was significantly reduced. 
Future studies will be required to determine which specific 
aspects  of  the  keratinocyte  response  to  TPA  are  com- 
promised. The function of the TPA-responsive  transcription 
factor AP-1 will be worth investigating, as the c-fos protein, 
an integral AP-1 component (Chiu et al.,  1988;  Sassone- 
Corsi et al.,  1988),  is highly expressed in the hair follicle 
(Fisher et al.,  1991). 
Expression of an E/a gene able to interfere with the Rb tu- 
mor suppressor protein, did not lead to epidermal hyperpla- 
sia,  nor increased skin tumor formation, or,  if anything, 
seemed to reduce it. The histological type of chemically in- 
duced tumors was similar in the E/a-positive and -negative 
mice,  suggesting  that  the  target  cell  population  and  its 
growth-differentiation behavior is not influenced by E/a ex- 
pression. Greenhalgh and Yuspa (1988) reported that carci- 
nogenic conversion of ras-transformed papilloma cells is not 
increased by an intact E/a oncogene.  Even in our trans- 
genics, assuming that the carcinogenic effects of DMBA are 
due to activation of the Ha-ms gene (Balmain et al., 1984), 
expression of the truncated E/a oncogene does not appear to 
exert a ms-cooperating activity. However,  it remains to be 
tested whether tumor-facilitating effects of  this transgene can 
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cinogenesis,  such as that of the Balb/c strain  (Hennings et 
al., 1981).  In any case, it has to be stressed that many nega- 
tive  regulatory  loops  may  act  in  vivo  to  maintain  skin 
homeostasis,  some of which are totally  unaffected by E/a 
NTd1646  activity.  For instance, gap junctional intercellular 
communication, which is an important mechanism to coor- 
dinate  control  of keratinocyte  growth  and  differentiation 
(Yamasaki,  1990), is not changed in keratinocytes express- 
ing this truncated  oncogene (our own unpublished results). 
In conclusion, expression of an E/a gene which interferes 
with known negative growth regulators, such as pl05-Rb and 
p60-cyclin  A,  does  not cause gross abnormalities  in ker- 
atinocyte growth and differentiation, nor facilitates neoplas- 
tic outgrowth. Rather, expression of this gene interferes with 
the regulatory mechanisms involved in keratinocyte hair fol- 
licle maturation.  Besides p105/p107/p60,  expression of this 
E/a gene may affect other unrelated regulatory proteins, for 
instance through its intact transactivation  domain (domain 3; 
Moran and Mathews,  1987).  An elucidation of the specific 
interactions involved should prove invaluable  to understand 
how a complex epithelial structure  such as the hair follicle 
is organized and maintained. 
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